The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors.
Cost NG, Krabbe LM, Bagrodia A, Margulis V. The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. Curr Opin Urol. 2013 Sep; 23(5):411-7.